Auriga USA reiterates a 'Buy' on Allscripts-Misys (Nasdaq: MDRX) and increases price target to $12.

Auriga analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE